Splanchnic ischemia-reperfusion in shock: Pathophysiology;Ischémie-reperfusion mésentérique lors des états de choc: Principaux aspects physiopathologiques

Reanimation

Volumn 12, Issue 6, 2003, Pages 441-448

  Tamion, F ^a   Clabault, K ^a   Bonmarchand, G ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Ischemia; Multiple organ failure; Polymorphonuclear leucocytes; Reactive oxygen species; Reperfusion injury; Splanchnic circulation

Indexed keywords

CYTOKINE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

BACTERIAL TRANSLOCATION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; INTESTINE ABSORPTION; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; ISCHEMIA; LUNG INJURY; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; SHOCK; SPLANCHNIC BLOOD FLOW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0141513906     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1624-0693(03)00116-6     Document Type: Short Survey

References (72)

1. Stechmiller JK, Treloar D, Allen N. Gut dysfunction in critically ill patients: a review of the literature. Am J Crit Care 1997;6:204-9.
2. Granger DN, Richardson PD, Kvietys PR, Mortillaro NA. Intestinal blood flow. Gastroenterology 1980;78:837-63.
3. Landow L, Andersen LW. Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 1994;38:626-39.
4. Hallback DA, Jodal M, Lundgren O. Intestinal countercurrent. Gastroenterology 1978;75:553-4.
5. Aranow JS, Fink MP. Determinants of intestinal barrier failure in critical illness. Br J Anaesth 1996;77:71-81.
6. Effros RM, Presberg KW. Gastric tonometry. Eur J Clin Invest 2000; 30:467-8.
7. Lebuffe G, Robin E, Vallet B. Gastric tonometry. Intensive Care Med 2001;27:317-9.
8. Vincent JL. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology. Crit Care 2001;5(Suppl 2):S1-5.
9. Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci 1994;307:284-92.
10. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117-34.
11. Schoenberg MH, Beger HG. Reperfusion injury after intestinal ischemia. Crit Care Med 1993;21:1376-86.
12. Grace PA. Ischaemia-reperfusion injury. Br J Surg 1994;81:637-47.
13. Korthuis RJ, Granger DN. Reactive oxygen metabolites, neutrophils, and the pathogenesis of ischemic-tissue/reperfusion. Clin Cardiol 1993;16(Suppl 1):119-26.
14. Morel Y. Influence du stress oxydant sur la régulation des gènes. Medecine/Science 1998;14:713-21.
15. Remick DG, Villarete L. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J Leukoc Biol 1996;59:471-5.
16. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 1996;24:1179-83.
17. Horie Y, Wolf R, Flores SC, McCord JM, Epstein CJ, Granger DN. Transgenic mice with increased copper/zinc-superoxide dismutase activity are resistant to hepatic leukostasis and capillary no-reflow after gut ischemia/reperfusion. Circ Res 1998;83:691-6.
18. Menconi MJ, Unno N, Smith M, Aguirre DE, Fink MP. Nitric oxide donor-induced hyperpermeability of cultured intestinal epithelial monolayers: role of superoxide radical, hydroxyl radical, and peroxynitrite. Biochim Biophys Acta 1998;1425:189-203.
19. Baeuerle PA, Rupec RA, Pahl HL. Reactive oxygen intermediates as second messengers of a general pathogen response m/s 1996;44:29-35.
20. May MJ, Ghosh S. Signal transduction through NF-kappa B. Immunol Today 1998;19:80-8.
21. Pahl HL, Baeuerle PA. The ER-overload response: activation of NF-kappa B. Trends Biochem Sci 1997;22:63-7.
22. Muller JM, Rupec RA, Baeuerle PA. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods 1997;11:301-12.
23. Jaeschke H. Xanthine oxidase-induced oxidant stress during hepatic ischemia-reperfusion: are we coming full circle after 20 years? Hepatology 2002;36:761-3.
24. Frederiks WM, Bosch KS. The role of xanthine oxidase in ischemia/reperfusion damage of rat liver. Histol Histopathol 1995; 10: 111-6.
25. Weinbroum A, Nielsen VG, Tan S, Gelman S, Matalon S, Skinner KA, et al. Liver ischemia-reperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase. Am J Physiol 1995;268(6 Pt 1):G988-96.
26. Nielsen VG, Tan S, Weinbroum A, McCammon AT, Samuelson PN, Gelman S, et al. Lung injury after hepatoenteric ischemia-reperfusion: role of xanthine oxidase. Am J Respir Crit Care Med 1996;154: 1364-9.
27. Canas PE. The role of xanthine oxidase and the effects of antioxidants in ischemia reperfusion cell injury. Acta Physiol Pharmacol Ther Latinoam 1999;49:13-20.
28. Hammerman C, Goldschmidt D, Caplan MS, Kaplan M, Schimmel MS, Eidelman AI, et al. Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase. J Pediatr Gastroenterol Nutr 1999;29:69-74.
29. Matsumura F, Yamaguchi Y, Goto M, Ichiguchi O, Akizuki E, Matsuda T, et al. Xanthine oxidase inhibition attenuates kupffer cell production of neutrophil chemoattractant following ischemia-reperfusion in rat liver. Hepatology 1998;28:1578-87.
30. Biffl WL, Moore EE. Splanchnic ischaemia/reperfusion and multiple organ failure. Br J Anaesth 1996;77:59-70.
31. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503-21.
32. Kim PK, Deutschman CS. Inflammatory responses and mediators. Surg Clin North Am 2000;80:885-94.
33. Lee WL, Downey GP. Leukocyte elastase: physiological functions and role in acute lung injury. Am J Respir Crit Care Med 2001;164: 896-904.
34. Eppihimer MJ, Granger DN. Ischemia/reperfusion-induced leukocyte-endothelial interactions in postcapillary venules. Shock 1997;8:16-25.
35. Hill J, Lindsay T, Valeri CR, Shepro D, Hechtman HB. A CD18 antibody prevents lung injury but not hypotension after intestinal ischemia-reperfusion. J Appl Physiol 1993;74:659-64.
36. Carden D, Xiao F, Moak C, Willis BH, Robinson_Jackson S, Alexander S. Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Physiol 1998;275(2 Pt 2):H385-92.
37. Babior BM. NADPH oxidase: an update. Blood 1999;93:1464-76.
38. Barry MC, Kelly C, Burke P, Sheehan S, Redmond HP, Bouchier_Hayes D. Immunological and physiological responses to aortic surgery: effect of reperfusion on neutrophil and monocyte activation and pulmonary function. Br J Surg 1997;84:513-9.
39. Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I. Regulatory functions of phospholipase A2. Crit Rev Immunol 1997;17:225-83.
40. Koike K, Moore EE, Moore FA, Kim FJ, Carl VS, Banerjee A. Gut phospholipase A2 mediates neutrophil priming and lung injury after mesenteric ischemia-reperfusion. Am J Physiol 1995;268(3 Pt 1): G397-403.
41. Lefer AM, Lefer DJ. Nitric oxide. II. Nitric oxide protects in intestinal inflammation. Am J Physiol 1999;276(3 Pt 1):G572-5.
42. Arnal JF, Dinh_Xuan AT, Pueyo M, Darblade B, Rami J. Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 1999;55:1078-87.
43. Koyanagi M, Egashira K, Kitamoto S, Ni W, Shimokawa H, Takeya M, et al. Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis. Circulation 2000;102:2243-8.
44. Spiecker M, Peng HB, Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 1997;272: 30969-74.
45. Steiner DR, Gonzalez NC, Wood JG. Interaction between reactive oxygen species and nitric oxide in the microvascular response to systemic hypoxia. J Appl Physiol 2002;93:1411-8.
46. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995;268(5 Pt 1):L699-722.
47. Szabo C. DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic Biol Med 1996;21:855-69.
48. Liaudet L. Poly(adenosine 5′-diphosphate) ribose polymerase activation as a cause of metabolic dysfunction in critical illness. Curr Opin Clin Nutr Metab Care 2002;5:175-84.
49. Oei SL, Griesenbeck J, Schweiger M. The role of poly(ADP-ribosyl) ation. Rev Physiol Biochem Pharmacol 1997;131:127-73.
50. Herceg Z, Wang ZQ. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat Res 2001;477:97-110.
51. Oliver FJ, Menissier_de_Murcia J, de_Murcia G. Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 1999;64:1282-8.
52. Thiemermann C, Bowes J, Myint FP, Vane JR. Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 1997;94:679-83.
53. Szabo A, Hake P, Salzman AL, Szabo C. 3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock. Shock 1998;10:347-53.
54. Virag L, Szabo C. The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors. Pharmacol Rev 2002;54:375-429.
55. Zingarelli B, Cuzzocrea S, Zsengeller Z, Salzman AL, Szabo C. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 1997;36:205-15.
56. Mazzon E, Dugo L, De SA, Li JH, Caputi AP, Zhang J, et al. Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion. Shock 2002;17:222-7.
57. Cuzzocrea S, Zingarelli B, Costantino G, Szabo A. Salzman AL, Caputi AP, et al. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 1997;121:1065-74.
58. Biffi WL, Moore EE, Moore FA, Barnett CC, Silliman CC, Peterson VM. Interleukin-6 stimulates neutrophil production of platelet-activating factor. J Leukoc Biol 1996;59:569-74.
59. Salzman AL. Nitric oxide in the gut. New Horiz 1995;3:352-64.
60. Grotz MR, Deitch EA, Ding J, Xu D, Huang Q, Regel G. Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann Surg 1999;229:478-86.
61. Baue AE. Sepsis, multi-organ dysfunction syndrome (MODS) and multiple organ failure (MOF). Prevention is better than treatment Minerva Anestesiol 1999;65:477-80.
62. Kong SE, Blennerhassett LR, Heel KA, McCauley RD, Hall JC. Ischaemia-reperfusion injury to the intestine. Aust N Z J Surg 1998; 68:554-61.
63. Koike K, Moore EE, Moore FA, Read RA, Carl VS, Banerjee A. Gut ischemia/reperfusion produces lung injury independent of endotoxin. Crit Care Med 1994;22:1438-44.
64. Moore EE, Moore FA, Franciose RJ, Kim FJ, Biffl WL, Banerjee A. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 1994;37:881-7.
65. Moore FA, Moore EE, Poggetti R, McAnena OJ, Peterson VM, Abernathy CM, et al. Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 1991;31: 629-36 discussion 636-8.
66. Gardiner KR, Rowlands BJ. Trauma and bacterial translocation. Br J Surg 1996;83:283.
67. Kubes P. The role of adhesion molecules and nitric oxide in intestinal and hepatic ischemia/reperfusion. Hepatogastroenterology 1999; 46(Suppl 2):1458-63.
68. Partrick DA, Moore EE, Moore FA, Biffl WL, Barnett CC. Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure. Am J Surg 1999;178:564-9.
69. Fontes B, Moore FA, Moore EE, Koike K, Kim F, Trew CE, et al. Gut ischemia induces bone marrow failure and increases risk of infection. J Surg Res 1994;57:505-9.
70. Xiao F, Eppihimer MJ, Young JA, Nguyen K, Carden DL. Lung neutrophil retention and injury after intestinal ischemia/reperfusion. Microcirculation 1997;4:359-67.
71. Poggetti RS, Moore FA, Moore EE, Bensard DD, Anderson BO, Banerjee A. Liver injury is a reversible neutrophil-mediated event following gut ischemia. Arch Surg 1992;127:175-9.
72. Poggetti RS, Moore FA, Moore EE, Koeike K, Banerjee A. Simultaneous liver and lung injury following gut ischemia is mediated by xanthine oxidase. J Trauma 1992;32:723-7.